Cargando…

RT-qPCR Testing of SARS-CoV-2: A Primer

Testing for the presence of coronavirus is an essential diagnostic tool for monitoring and managing the current COVID-19 pandemic. The only reliable test in current use for testing acute infection targets the genome of SARS-CoV-2, and the most widely used method is quantitative fluorescence-based re...

Descripción completa

Detalles Bibliográficos
Autores principales: Bustin, Stephen A., Nolan, Tania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215906/
https://www.ncbi.nlm.nih.gov/pubmed/32344568
http://dx.doi.org/10.3390/ijms21083004
_version_ 1783532296974893056
author Bustin, Stephen A.
Nolan, Tania
author_facet Bustin, Stephen A.
Nolan, Tania
author_sort Bustin, Stephen A.
collection PubMed
description Testing for the presence of coronavirus is an essential diagnostic tool for monitoring and managing the current COVID-19 pandemic. The only reliable test in current use for testing acute infection targets the genome of SARS-CoV-2, and the most widely used method is quantitative fluorescence-based reverse transcription polymerase chain reaction (RT-qPCR). Despite its ubiquity, there is a significant amount of uncertainty about how this test works, potential throughput and reliability. This has resulted in widespread misrepresentation of the problems faced using this test during the current COVID-19 epidemic. This primer provides simple, straightforward and impartial information about RT-qPCR.
format Online
Article
Text
id pubmed-7215906
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72159062020-05-22 RT-qPCR Testing of SARS-CoV-2: A Primer Bustin, Stephen A. Nolan, Tania Int J Mol Sci Commentary Testing for the presence of coronavirus is an essential diagnostic tool for monitoring and managing the current COVID-19 pandemic. The only reliable test in current use for testing acute infection targets the genome of SARS-CoV-2, and the most widely used method is quantitative fluorescence-based reverse transcription polymerase chain reaction (RT-qPCR). Despite its ubiquity, there is a significant amount of uncertainty about how this test works, potential throughput and reliability. This has resulted in widespread misrepresentation of the problems faced using this test during the current COVID-19 epidemic. This primer provides simple, straightforward and impartial information about RT-qPCR. MDPI 2020-04-24 /pmc/articles/PMC7215906/ /pubmed/32344568 http://dx.doi.org/10.3390/ijms21083004 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Bustin, Stephen A.
Nolan, Tania
RT-qPCR Testing of SARS-CoV-2: A Primer
title RT-qPCR Testing of SARS-CoV-2: A Primer
title_full RT-qPCR Testing of SARS-CoV-2: A Primer
title_fullStr RT-qPCR Testing of SARS-CoV-2: A Primer
title_full_unstemmed RT-qPCR Testing of SARS-CoV-2: A Primer
title_short RT-qPCR Testing of SARS-CoV-2: A Primer
title_sort rt-qpcr testing of sars-cov-2: a primer
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215906/
https://www.ncbi.nlm.nih.gov/pubmed/32344568
http://dx.doi.org/10.3390/ijms21083004
work_keys_str_mv AT bustinstephena rtqpcrtestingofsarscov2aprimer
AT nolantania rtqpcrtestingofsarscov2aprimer